Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|February 9, 2002
HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis CVincent Di Martino, Thierry Thevenot, Nathalie Boyer, et al.
World Journal of Gastroenterology|June 28, 2012
Impact of ribavirin dose on retreatment of chronic hepatitis C patientsChristiane Stern, Michelle Martinot-Peignoux, Marie Pierre Ripault, et al.
Antiviral Therapy|May 22, 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinDominique Larrey, Christophe Carenco, Dominique Guyader, et al.
Hepatic Medicine : Evidence and Research|January 4, 2018
Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohortBlaise K Kutala, Feryel Mouri, Corinne Castelnau, et al.
Gastroenterology|June 10, 2006
Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirinValérie Paradis, Tarik Asselah, Delphine Dargere, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver diseaseBlaise K Kutala, Jeremie Guedj, Tarik Asselah, et al.
Journal of Viral Hepatitis|March 7, 2025
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency DepartmentPrabakar Vaittinada Ayar, Jamal Abdelkader, Matthieu Gay, et al.
Hepatology (Baltimore, Md.)|July 31, 2007
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective studyPierre Bedossa, Rami Moucari, Emna Chelbi, et al.
Journal of Hepatology|April 12, 2002
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriersMichelle Martinot-Peignoux, Nathalie Boyer, Magalie Colombat, et al.
Plos One|April 7, 2015
IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis CEmilie Estrabaud, Kevin Appourchaux, Ivan Bièche, et al.
Pageof 5